Demetri GD - Search Results

1

Benefits of epoetin alfa in anemic breast cancer patients receiving chemotherapy.

Demetri GD, Gabrilove JL, Blasi MV, Hill RJ Jr, Glaspy J. Demetri GD, et al. Clin Breast Cancer. 2002 Apr;3(1):45-51. doi: 10.3816/CBC.2002.n.011. Clin Breast Cancer. 2002. PMID: 12020395

2

Changes in Tc-99m radionuclide bone scan images and peripheralization of marrow hematopoietic activity associated with the administration of granulocyte colony stimulating factor as an adjunct to dose-intensified chemotherapy for breast cancer. A case report.

Salgia R, Demetri GD, Kaplan WD. Salgia R, et al. Among authors: demetri gd. Cancer. 1994 Oct 1;74(7):1887-90. doi: 10.1002/1097-0142(19941001)74:7<1887::aid-cncr2820740710>3.0.co;2-6. Cancer. 1994. PMID: 7521785

3

The use of hematopoietic growth factors to support cytotoxic chemotherapy for patients with breast cancer.

Demetri GD. Demetri GD. Hematol Oncol Clin North Am. 1994 Feb;8(1):233-49. Hematol Oncol Clin North Am. 1994. PMID: 8150782 Review.

4

The emergence of peripheral blood progenitor cells to support intensive chemotherapy for patients with breast cancer.

Demetri GD. Demetri GD. Pharmacotherapy. 1996 May-Jun;16(3 Pt 2):94S-100S. Pharmacotherapy. 1996. PMID: 8726588

5

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

Demetri GD, Kris M, Wade J, Degos L, Cella D. Demetri GD, et al. J Clin Oncol. 1998 Oct;16(10):3412-25. doi: 10.1200/JCO.1998.16.10.3412. J Clin Oncol. 1998. PMID: 9779721

6

A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy.

Glaspy J, Jadeja JS, Justice G, Kessler J, Richards D, Schwartzberg L, Rigas J, Kuter D, Harmon D, Prow D, Demetri G, Gordon D, Arseneau J, Saven A, Hynes H, Boccia R, O'Byrne J, Colowick AB. Glaspy J, et al. Br J Cancer. 2001 Apr;84 Suppl 1(Suppl 1):17-23. doi: 10.1054/bjoc.2001.1748. Br J Cancer. 2001. PMID: 11308270 Free PMC article. Clinical Trial.

7

Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy.

Demetri GD. Demetri GD. Br J Cancer. 2001 Apr;84 Suppl 1(Suppl 1):31-7. doi: 10.1054/bjoc.2001.1750. Br J Cancer. 2001. PMID: 11308272 Free PMC article. Review.

8

Comparable efficacy of epoetin alfa for anemic cancer patients receiving platinum- and nonplatinum-based chemotherapy: a retrospective subanalysis of two large, community-based trials.

Glaspy J, Degos L, Dicato M, Demetri GD. Glaspy J, et al. Among authors: demetri gd. Oncologist. 2002;7(2):126-35. doi: 10.1634/theoncologist.7-2-126. Oncologist. 2002. PMID: 11961196 Free article. Clinical Trial.

9

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy.

Crawford J, Cella D, Cleeland CS, Cremieux PY, Demetri GD, Sarokhan BJ, Slavin MB, Glaspy JA. Crawford J, et al. Among authors: demetri gd. Cancer. 2002 Aug 15;95(4):888-95. doi: 10.1002/cncr.10763. Cancer. 2002. PMID: 12209734 Free article. Clinical Trial.

10

Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer.

Esteva FJ, Glaspy J, Baidas S, Laufman L, Hutchins L, Dickler M, Tripathy D, Cohen R, DeMichele A, Yocum RC, Osborne CK, Hayes DF, Hortobagyi GN, Winer E, Demetri GD. Esteva FJ, et al. Among authors: demetri gd. J Clin Oncol. 2003 Mar 15;21(6):999-1006. doi: 10.1200/JCO.2003.05.068. J Clin Oncol. 2003. PMID: 12637463 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

351 results

Search Page